Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Some medications can cause acne, and stopping these drugs is the main treatment.

Psoriasis can cause temporary or permanent hair loss.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document says that there are treatments for hair and nail diseases.

Using cidofovir cream for a rare skin disease can cause skin darkening.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.